These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10998082)

  • 1. A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.
    De Miguel LS; Jiménez A; Montón M; Farré J; Del Mar Arriero M; Rodríguez-Feo JA; García-Cañete J; Rico L; Gómez J; Núñez A; Casado S; Farré AL
    Eur J Clin Invest; 2000 Sep; 30(9):811-7. PubMed ID: 10998082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of triflusal on human platelet aggregation and secretion: the role of nitric oxide].
    Sánchez de Miguel L; Montón M; Mar Arriero M; Guerra JI; Jiménez A; González-Fernández F; García-Durán M; Bellver T; Rico L; Romero J; Gómez J; Núñez A; Marcos P; Ayala R; Farré J; Casado S; López-Farré A
    Rev Esp Cardiol; 2000 Feb; 53(2):205-11. PubMed ID: 10734753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.
    Sánchez de Miguel L; Casado S; Farré J; García-Durán M; Rico LA; Montón M; Romero J; Bellver T; Sierra MP; Guerra JI; Mata P; Esteban A; López-Farré A
    Eur J Pharmacol; 1998 Feb; 343(1):57-65. PubMed ID: 9551715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
    Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
    Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide released from activated platelets inhibits platelet recruitment.
    Freedman JE; Loscalzo J; Barnard MR; Alpert C; Keaney JF; Michelson AD
    J Clin Invest; 1997 Jul; 100(2):350-6. PubMed ID: 9218511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW; Mackie IJ; Machin SJ
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
    Bayón Y; Alonso A; Sánchez Crespo M
    Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.
    De La Cruz JP; Villalobos MA; García PJ; Smith-Agreda JM; Sánchez de la Cuesta F
    Eur J Clin Pharmacol; 1995; 47(6):497-502. PubMed ID: 7768251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet antiaggregatory effect of triflusal in human whole blood.
    de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Kalinowski L; Matys T; Chabielska E; Buczko W; Malinski T
    Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia.
    Dias-Da-Motta P; Arruda VR; Muscará MN; Saad ST; De Nucci G; Costa FF; Condino-Neto A
    Br J Haematol; 1996 May; 93(2):333-40. PubMed ID: 8639425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitric oxide modulation on systemic haemodynamics and platelet activation determined by P-selectin expression.
    Ritchie JL; Alexander HD; Allen P; Morgan D; McVeigh GE
    Br J Haematol; 2002 Mar; 116(4):892-8. PubMed ID: 11886397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation.
    Laffi G; Foschi M; Masini E; Simoni A; Mugnai L; La Villa G; Barletta G; Mannaioni PF; Gentilini P
    Hepatology; 1995 Dec; 22(6):1666-73. PubMed ID: 7489972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of triflusal on platelet activation after coronary artery bypass graft.
    Prieto MA; De La Cruz JP; Del Prado MF; Sánchez de la Cuesta F
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):191-7. PubMed ID: 10759013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.
    Homoncik M; Jilma B; Donham DC; Frossard M; Keuzer C; Sorenson JR
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):131-8. PubMed ID: 12632022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous nitric oxide inhibits platelet activation in whole blood.
    Yoshimoto H; Suehiro A; Kakishita E
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):109-15. PubMed ID: 9890404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
    Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.